Weiss Multi-Strategy Advisers’s Adaptimmune Therapeutics ADAP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-40,000
| Closed | -$161K | – | 457 |
|
2019
Q2 | $161K | Sell |
40,000
-25,000
| -38% | -$101K | ﹤0.01% | 390 |
|
2019
Q1 | $280K | Hold |
65,000
| – | – | 0.01% | 390 |
|
2018
Q4 | $374K | Sell |
65,000
-5,000
| -7% | -$28.8K | 0.02% | 307 |
|
2018
Q3 | $949K | Sell |
70,000
-10,000
| -13% | -$136K | 0.03% | 319 |
|
2018
Q2 | $950K | Hold |
80,000
| – | – | 0.02% | 348 |
|
2018
Q1 | $898K | Sell |
80,000
-20,000
| -20% | -$225K | 0.03% | 353 |
|
2017
Q4 | $668K | Sell |
100,000
-1,000
| -1% | -$6.68K | 0.02% | 375 |
|
2017
Q3 | $827K | Hold |
101,000
| – | – | 0.03% | 327 |
|
2017
Q2 | $453K | Sell |
101,000
-9,000
| -8% | -$40.4K | 0.02% | 394 |
|
2017
Q1 | $606K | Hold |
110,000
| – | – | 0.02% | 359 |
|
2016
Q4 | $446K | Buy |
110,000
+46,000
| +72% | +$187K | 0.02% | 291 |
|
2016
Q3 | $451K | Sell |
64,000
-1,610
| -2% | -$11.3K | 0.03% | 289 |
|
2016
Q2 | $535K | Sell |
65,610
-44,390
| -40% | -$362K | 0.04% | 280 |
|
2016
Q1 | $894K | Buy |
110,000
+7,000
| +7% | +$56.9K | 0.04% | 302 |
|
2015
Q4 | $1.24M | Sell |
103,000
-14,000
| -12% | -$169K | 0.09% | 190 |
|
2015
Q3 | $1.4M | Sell |
117,000
-3,000
| -3% | -$35.9K | 0.06% | 191 |
|
2015
Q2 | $2.2M | Buy |
+120,000
| New | +$2.2M | 0.09% | 200 |
|